Hypophosphatemia After Intravenous Ferric Carboxymaltose in Heart Transplant Patients

被引:0
|
作者
Santulario-Verdu, L. [1 ]
Echeverry-Navarrete, E. [2 ]
Diez-Lopez, C. [2 ]
Canedo-Castelo, M. [1 ]
Juvany-Roig, R. [1 ]
Garcia-Romero, E. [2 ]
Roca-Elias, J. [2 ]
Manito-Lorite, N. [2 ]
Gonzalez-Costello, J. [2 ]
机构
[1] Bellvitge Univ Hosp, Pharm, Barcelona, Spain
[2] Bellvitge Univ Hosp, Cardiol, Barcelona, Spain
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
512
引用
收藏
页码:S220 / S221
页数:2
相关论文
共 50 条
  • [41] Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction
    Lopez-Vilella, Raquel
    Lozano-Edo, Silvia
    Arenas Martin, Patricia
    Jover-Pastor, Pablo
    Ezzitouny, Meryem
    Sorolla Romero, Jose
    Calvo Asensio, Maria
    Martinez-Sole, Julia
    Guerrero Cervera, Borja
    Sanchez Martinez, Jose Carlos
    Donoso Trenado, Victor
    Sanchez-Lazaro, Ignacio
    Martinez Dolz, Luis
    Almenar Bonet, Luis
    ESC HEART FAILURE, 2022, 9 (01): : 133 - 145
  • [42] Effects of Ferric Carboxymaltose vs Ferumoxytol on Hypophosphatemia in Patients With IronDeficiency Anemia Due to Gastrointestinal Disorders
    Dahl, Naomi V.
    Sadiq, Amama
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S636 - S637
  • [43] Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases
    Salvadori, Ugo
    Vittadello, Fabio
    Al-Khaffaf, Ahmad
    Maier, Armin
    Cappelletto, Paola C.
    Daves, Massimo
    Raffeiner, Bernd
    BLOOD TRANSFUSION, 2020, 18 (03) : 176 - 181
  • [44] SEVERE HYPOPHOSPHATEMIA INDUCED BY FERRIC CARBOXYMALTOSE IN A PATIENT WITH IRON DEFICIENCY ANEMIA
    Abdelgadir, Yasir
    Abdelgadir, Eman
    Cheungpasitporn, Wisit
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [45] Incidence of ferric carboxymaltose hypophosphatemia in iron deficiency anaemia in patients undergoing surgery for digestive neoplasia
    Guardiola Ponti, H.
    Hernandez Rodriguez, I.
    Grau Cat, J.
    Martinez Couselo, S.
    Sancho Cerro, A.
    Joaquin Ortiz, C.
    Ramos Rodas, A. E.
    Garsot Savall, E.
    Jimenez Capel, Y.
    Montane Esteva, E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 35 - 36
  • [46] Severe Hypophosphatemia Following Ferric Carboxymaltose in a Patient With Inflammatory Bowel Disease
    Ali, Abuobeida
    Elmdaah, Ali
    Mustafa, Ahmed Mohammed
    Kanagavelu, Aravind Sunderavel Kumaravel
    Mohamed, Nader
    Sayed, Saber
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [47] Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients
    Taha, Amira Mohamed
    Elsaeidy, Ahmed Saad
    Nada, Sarah A.
    Sharma, Sadish
    Ghonaim, Mohamed M.
    Ahsan, Areeba
    Mourid, Marina Ramzy
    Abouelmagd, Khaled
    CLINICAL DRUG INVESTIGATION, 2024, 44 (12) : 879 - 896
  • [48] Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
    Anker, Stefan D.
    Comin Colet, Josep
    Filippatos, Gerasimos
    Willenheimer, Ronnie
    Dickstein, Kenneth
    Drexler, Helmut
    Luescher, Thomas F.
    Bart, Boris
    Banasiak, Waldemar
    Niegowska, Joanna
    Kirwan, Bridget-Anne
    Mori, Claudio
    Rothe, Barbara von Eisenhart
    Pocock, Stuart J.
    Poole-Wilson, Philip A.
    Ponikowski, Piotr
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25): : 2436 - 2448
  • [49] Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose
    Schaefer, Benedikt
    Zoller, Heinz
    Wolf, Myles
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (04): : 1009 - 1019
  • [50] Epstein-Barr virus infection after intravenous ferric carboxymaltose infusion
    Park, C. J.
    Wiseman, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 169 - 170